Navigation Links
Conforma-K™

ProductsConforma-K™
Company Conforma Laboratories, Inc.
Item Conforma-K™
Features 
  • Conforma-K lenses will provide the design and material combination that will reduce the challenge and increase your success rate.
  • Conforma-K lenses are only available in the Boston ES and Boston XO materials.
  • These proven materials will provide the oxygen delivery, wetting and stability essential to maximizing on-eye performance.
  • The Conforma-K geometry enables efficient masking of irregular corneal astigmatism, typical of most conic corneas.
  • The Conforma-K geometry provides a series of aspheric curves that progressively flatten from the paracentral section to the most peripheral area of the lens.
  • This progressive flattening minimizes localized pressure points resulting in an improved lens to cornea fitting relationship.
  • Better fit and alignment means improved comfort and physiology.
Description Keratoconus detected early is best corrected with GP lenses. Even though good spectacle acuity may still be present, GP lenses will help the patient adapt to the inevitable. GP lenses will neutralize the distortions of the corneal surface and provide improved visual acuity.

Keratoconus is a fitting challenge for even the most experienced practitioner. Each case is unique and requires a strong rigid lens background with good fluorescein evaluation skills. Conforma-K lenses will provide the design and material combination that will reduce the challenge and increase your success rate. Conforma-K lenses are only available in the Boston ES and Boston XO materials. These proven materials will provide the oxygen delivery, wetting and stability essential to maximizing on-eye performance. The Conforma-K geometry enables efficient masking of irregular corneal astigmatism, typical of most conic corneas. The Conforma-K geometry provides a series of aspheric curves that progressively flatten from the paracentral section to the most peripheral area of the lens. This progressive flattening minimizes localized pressure points resulting in an improved lens to cornea fitting relationship. Better fit and alignment means improved comfort and physiology.

Info Conforma Laboratories, Inc.
Customer Service: (800) 426-1700
Web site: http://www.conforma.com

Related medicine products :

1. 34670x Bagolinis Striated Lenses Pair
2. Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted
3. Khosla Non-Illuminated Trial Lens Set, With Lenses Mounted
4. Crazy Lenses
5. Focus 1-2 Week Lenses
6. Focus Monthly Lenses
7. Bandage Lenses
8. Multi-Piece PMMA Intraocular Lenses
9. Orthokeratology (oprifocon A) Contact Lenses
10. JSZ Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear
11. RGP OrthoK Lenses
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 50532 1VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 50532 2VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 50532 3VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 50532 4Colorectal cancer 9090 1Genetically engineered mice yield clues to knocking out cancer 9086 1Genetically engineered mice yield clues to knocking out cancer 9086 2